Kyoung-Ho Pyo

Title: Kyoung-Ho Pyo: Innovator in Cancer Treatment

Introduction

Kyoung-Ho Pyo is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of oncology, particularly in the treatment of non-small cell lung cancer. His innovative approach focuses on utilizing statin-based drugs to combat cancer that has developed resistance to conventional therapies.

Latest Patents

Kyoung-Ho Pyo holds a patent for the "Use of statin-based drug for treatment of EML4-ALK-positive non-small cell lung cancer progressing on ALK inhibitor." This patent provides a pharmaceutical composition that exhibits therapeutic efficacy against EML4-ALK-positive non-small cell lung cancer. The invention also includes a method for treating this type of cancer, offering valuable information for drug selection to determine the administration of statin-based drugs to affected patients.

Career Highlights

Throughout his career, Kyoung-Ho Pyo has worked with reputable organizations, including Jeuk Co., Ltd. and Yonsei University. His experience in these institutions has allowed him to develop and refine his innovative ideas in cancer treatment.

Collaborations

Kyoung-Ho Pyo has collaborated with esteemed colleagues such as Byoung Chul Cho and Mi-Ran Yun. These partnerships have contributed to the advancement of his research and the successful development of his patented treatments.

Conclusion

Kyoung-Ho Pyo's work in the field of cancer treatment exemplifies the impact of innovative thinking in medicine. His contributions, particularly through his patent on statin-based drugs, offer hope for patients facing challenging cancer diagnoses.